My bookmarksSign up free

2010/135/: Commission Decision of 2 March 2010 concerning… Article 2

2010/135/: Commission Decision of 2 March 2010 concerning… Article 2

Product

Article 2

1.   The genetically modified organism to be placed on the market as or in products, hereinafter ‘the product’ is potato ( Solanum tuberosum L.) modified for enhanced content of the amylopectin component of starch, which has been transformed with Agrobacterium tumefaciens , using the vector pHoxwG, resulting in line EH92-527-1. The product contains the following DNA in two cassettes: (a) Cassette 1: an nptII -type kanamycin resistance gene originating from Tn5, under the regulation of a nopaline-synthase promoter for expression in plant tissue and terminated by a polyadenylation sequence from the Agrobacterium tumefaciens nopaline-synthase gene; (b) Cassette 2: a segment of the potato gbss gene encoding for granule bound starch synthase protein inserted in reversed orientation under the control of the gbss-promoter isolated from potato, and terminated by a polyadenylation sequence from the Agrobacterium tumefaciens nopaline-synthase gene. 2.   The consent shall cover genetically modified Solanum tuberosum L. line EH92-527-1 as or in products.

Read the full instrument →

Other provisions in 2010/135/: Commission Decision of 2 March 2010 concerning…

Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗ · Data as of 2026-07-04

CitationArticle 2 of 2010/135/: Commission Decision of 2 March 2010 concerning… (LawPlayer, data as of 2026-07-04)

© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.

What to look at next